These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 23238443

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.
    Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR.
    Invest Ophthalmol Vis Sci; 2012 Jan 25; 53(1):267-72. PubMed ID: 22159005
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Visual recovery in treated bacterial keratitis.
    Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Ray KJ, Zegans ME, Acharya NR, Lietman TM, Keenan JD, Steroids for Corneal Ulcers Trial Group.
    Ophthalmology; 2014 Jun 25; 121(6):1310-1. PubMed ID: 24612976
    [Abstract] [Full Text] [Related]

  • 5. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
    Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR, Steroids for Corneal Ulcers Trial Group.
    Arch Ophthalmol; 2012 Feb 25; 130(2):143-50. PubMed ID: 21987582
    [Abstract] [Full Text] [Related]

  • 6. The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
    Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, O'Brien KS, Glidden DV, Ray KJ, Oldenburg CE, Zegans ME, Whitcher JP, McLeod SD, Porco TC, Lietman TM, Acharya NR, Steroids for Corneal Ulcers Trial Group.
    Am J Ophthalmol; 2014 Feb 25; 157(2):327-333.e3. PubMed ID: 24315294
    [Abstract] [Full Text] [Related]

  • 7. Nocardia keratitis: clinical course and effect of corticosteroids.
    Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Priya JL, Sy A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Lietman TM, Acharya NR.
    Am J Ophthalmol; 2012 Dec 25; 154(6):934-939.e1. PubMed ID: 22959881
    [Abstract] [Full Text] [Related]

  • 8. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial.
    See CW, Srinivasan M, Saravanan S, Oldenburg CE, Esterberg EJ, Ray KJ, Glaser TS, Tu EY, Zegans ME, McLeod SD, Acharya NR, Lietman TM.
    Ophthalmic Epidemiol; 2012 Dec 25; 19(6):407-13. PubMed ID: 23171211
    [Abstract] [Full Text] [Related]

  • 9. The steroids for corneal ulcers trial: study design and baseline characteristics.
    Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR, Steroids for Corneal Ulcers Trial Group.
    Arch Ophthalmol; 2012 Feb 25; 130(2):151-7. PubMed ID: 21987581
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.
    Borkar DS, Fleiszig SM, Leong C, Lalitha P, Srinivasan M, Ghanekar AA, Tam C, Li WY, Zegans ME, McLeod SD, Lietman TM, Acharya NR.
    JAMA Ophthalmol; 2013 Feb 25; 131(2):147-53. PubMed ID: 23411878
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Shah VM, Tandon R, Satpathy G, Nayak N, Chawla B, Agarwal T, Sharma N, Titiyal JS, Vajpayee RB.
    Cornea; 2010 Jul 25; 29(7):751-7. PubMed ID: 20489580
    [Abstract] [Full Text] [Related]

  • 16. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.
    Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Cevallos V, Oldenburg CE, Ray KJ, Toutain-Kidd CM, Glidden DV, Zegans ME, McLeod SD, Acharya NR, Lietman TM.
    Clin Infect Dis; 2012 May 25; 54(10):1381-7. PubMed ID: 22447793
    [Abstract] [Full Text] [Related]

  • 17. Does in vitro susceptibility predict clinical outcome in bacterial keratitis?
    Chen A, Prajna L, Srinivasan M, Mahalakshmi R, Whitcher JP, McLeod S, Lietman TM, Acharya NR.
    Am J Ophthalmol; 2008 Mar 25; 145(3):409-412. PubMed ID: 18207124
    [Abstract] [Full Text] [Related]

  • 18. Corticosteroids for bacterial corneal ulcers.
    Srinivasan M, Lalitha P, Mahalakshmi R, Prajna NV, Mascarenhas J, Chidambaram JD, Lee S, Hong KC, Zegans M, Glidden DV, McLeod S, Whitcher JP, Lietman TM, Acharya NR.
    Br J Ophthalmol; 2009 Feb 25; 93(2):198-202. PubMed ID: 18829631
    [Abstract] [Full Text] [Related]

  • 19. Early addition of topical corticosteroids in the treatment of bacterial keratitis.
    Ray KJ, Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Glidden DV, Oldenburg CE, Sun CQ, Zegans ME, McLeod SD, Acharya NR, Lietman TM.
    JAMA Ophthalmol; 2014 Jun 25; 132(6):737-41. PubMed ID: 24763755
    [Abstract] [Full Text] [Related]

  • 20. Differentiation of etiologic agents of bacterial keratitis from presentation characteristics.
    Mascarenhas J, Srinivasan M, Chen M, Rajaraman R, Ravindran M, Lalitha P, Oldenburg CE, Ray KJ, Glidden DV, Costanza S, Lietman TM, Acharya NR.
    Int Ophthalmol; 2012 Dec 25; 32(6):531-8. PubMed ID: 22752605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.